No one can have failed to notice the austerity measures being put in
place across all government departments with "we're in this together"
becoming the rallying cry of the coalition government. In the spirit of
this, the National Rheumatoid Arthritis Society are using the occasion
of World Arthritis Day on the 12th October to publish their new
Responsibility Deal, demonstrating that as well as rights, patients also
have responsibilities, as do all those involved in the health, social
care and policy making process.
The Responsibility Deal is a series of pledges that all those with an
active interest in rheumatoid arthritis (RA) can sign up to - patients,
carers, health care professionals and policy makers. Each pledge
indicates a willingness to help NRAS work together with the rheumatology
community to raise awareness of RA, improve access to services and
medicines, empower people to self manage their condition more
effectively and, ultimately, lead to a better quality of life for all
people with the disease. The deal was developed following a consultation
exercise involving nearly 700 people, asking them about their views and
what they would do to make a difference.
"The Responsibility Deal is based on the principle that we all have
obligations and responsibilities; and we all can play our part to help
ensure that health and social care services across the UK deliver better
standards of care, high quality treatment and support services so that
people with RA can get the care they both need and deserve" said Ailsa
Bosworth, Chief Executive of the National Rheumatoid Arthritis Society.
"The Responsibility Deal puts into simple words a lot of incredibly
sensible, achievable and really important principles that all those
involved can sign up to and help make the system more equitable in the
UK. I for one will be pledging my commitment to it" said Professor David
Scott, Consultant Rheumatologist at Norfolk and Norwich University
Hospital NHS Trust and Chief Medical Advisor to NRAS.
Rheumatoid arthritis is an incurable disease affecting around 690,000
people across the UK, with a further 30,000 new cases diagnosed each
year. The condition costs the NHS £560 million pounds each year in
England alone but if you include social costs then this can rise to £4.8
billion and when the devolved nations are added, the figures are
substantially higher.